Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1809 1
1886 1
1907 1
1912 1
1914 1
1917 2
1918 4
1919 1
1920 1
1922 2
1923 1
1924 3
1925 4
1926 1
1928 1
1931 1
1934 2
1940 1
1943 2
1944 1
1945 3
1946 5
1947 3
1948 4
1949 6
1950 6
1951 3
1952 1
1953 6
1954 3
1955 4
1956 6
1957 4
1958 5
1959 13
1960 5
1961 7
1962 8
1963 14
1964 16
1965 11
1966 7
1967 6
1968 10
1969 12
1970 12
1971 7
1972 13
1973 17
1974 10
1975 13
1976 15
1977 17
1978 12
1979 17
1980 17
1981 24
1982 21
1983 38
1984 31
1985 33
1986 35
1987 28
1988 32
1989 34
1990 31
1991 34
1992 57
1993 49
1994 40
1995 34
1996 54
1997 51
1998 34
1999 57
2000 45
2001 41
2002 50
2003 45
2004 43
2005 55
2006 67
2007 86
2008 79
2009 81
2010 100
2011 99
2012 114
2013 123
2014 103
2015 115
2016 103
2017 113
2018 124
2019 108
2020 126
2021 126
2022 114
2023 10
Text availability
Article attribute
Article type
Publication date

Search Results

2,910 results
Results by year
Filters applied: . Clear all
Page 1
Deep vein thrombosis in pediatric patients.
Jaffray J, Young G. Jaffray J, et al. Among authors: young g. Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26881. Epub 2017 Nov 8. Pediatr Blood Cancer. 2018. PMID: 29115714 Review.
Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation.
Jiao H, Wachsmuth L, Kumari S, Schwarzer R, Lin J, Eren RO, Fisher A, Lane R, Young GR, Kassiotis G, Kaiser WJ, Pasparakis M. Jiao H, et al. Among authors: young gr. Nature. 2020 Apr;580(7803):391-395. doi: 10.1038/s41586-020-2129-8. Epub 2020 Mar 25. Nature. 2020. PMID: 32296175 Free PMC article.
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators. Male C, et al. Among authors: young g. Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5. Lancet Haematol. 2020. PMID: 31699660 Free article. Clinical Trial.
Diagnosis and treatment of hemophilia.
Kizilocak H, Young G. Kizilocak H, et al. Among authors: young g. Clin Adv Hematol Oncol. 2019 Jun;17(6):344-351. Clin Adv Hematol Oncol. 2019. PMID: 31437138 Review.
Direct oral anticoagulants for use in paediatrics.
Jaffray J, Young G. Jaffray J, et al. Among authors: young g. Lancet Child Adolesc Health. 2022 Mar;6(3):207-214. doi: 10.1016/S2352-4642(21)00343-6. Epub 2022 Jan 13. Lancet Child Adolesc Health. 2022. PMID: 35033222 Review.
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies.
Callaghan MU, Negrier C, Paz-Priel I, Chang T, Chebon S, Lehle M, Mahlangu J, Young G, Kruse-Jarres R, Mancuso ME, Niggli M, Howard M, Bienz NS, Shima M, Jiménez-Yuste V, Schmitt C, Asikanius E, Levy GG, Pipe SW, Oldenburg J. Callaghan MU, et al. Among authors: young g. Blood. 2021 Apr 22;137(16):2231-2242. doi: 10.1182/blood.2020009217. Blood. 2021. PMID: 33512413 Free PMC article. Clinical Trial.
ADAR1 averts fatal type I interferon induction by ZBP1.
Jiao H, Wachsmuth L, Wolf S, Lohmann J, Nagata M, Kaya GG, Oikonomou N, Kondylis V, Rogg M, Diebold M, Tröder SE, Zevnik B, Prinz M, Schell C, Young GR, Kassiotis G, Pasparakis M. Jiao H, et al. Among authors: young gr. Nature. 2022 Jul;607(7920):776-783. doi: 10.1038/s41586-022-04878-9. Epub 2022 Jul 20. Nature. 2022. PMID: 35859176 Free PMC article.
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation.
Young G, Lensing AWA, Monagle P, Male C, Thelen K, Willmann S, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bajolle F, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Beyer-Westendorf J, Martinelli I, Massicotte MP, Smith WT, Berkowitz SD, Schmidt S, Price V, Prins MH, Kubitza D; EINSTEIN-Jr. Phase 3 Investigators. Young G, et al. J Thromb Haemost. 2020 Jul;18(7):1672-1685. doi: 10.1111/jth.14813. Epub 2020 Jun 4. J Thromb Haemost. 2020. PMID: 32246743 Free article. Clinical Trial.
2,910 results